课题基金 / 基金详情

HISTONE AND DNA ADDUCTS IN HUMAN LUNG CELLS

HISTONE AND DNA ADDUCTS IN HUMAN LUNG CELLS
人肺细胞中的组蛋白和 DNA 加合物
批准号:
3755341
负责人:
STEVEN R TANNENBAUM
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

STEVEN R TANNENBAUM的其他基金

相似基金

相关文献

中文摘要
翻译
本项目的总体目标是开发和应用 检测人体肺部接触的分析方法 致突变和致癌多环芳烃的活性代谢物 烃类,包括苯并[a]芘,环戊[cd]芘, 荧蒽和其他突出的诱变剂发现了这个程序 项目 PAH的DNA和组蛋白加合物将在三个 人肺组织的类型:手术来源的大块组织,支气管 通过刷检活检获得上皮细胞,并解剖解剖 整个肺。 组蛋白加合物将通过低温荧光法测定 谱线窄化光谱法和气相色谱-质谱法。 DNA 将通过新开发的35 S-后标记技术测定加合物。 将结果与酶活性,突变谱, 以及其他项目确定的特定突变的定位, 了解化学致癌物加合物的作用 在人类肺癌的发展中起着重要作用。
英文摘要
The overall objective of this project is the development and application of analytical methods for the detection of human pulmonary exposure to active metabolites of mutagenic and carcinogenic polycyclic aromatic hydrocarbons, including benzo[a]pyrene, cyclopental[cd]pyrene, fluoranthene, and other prominent mutagens discovered by this program project. DNA and histone adducts of the PAH will be determined in three types of human lung tissue:surgically derived bulk tissue, bronchial epithelial cells obtained by brush biopsy, and anatomically dissected whole lungs. Histone adducts will be assayed by cryogenic fluorescence line narrowing spectrometry and gas chromatography-mass spectrometry. DNA adducts will be assayed by a newly developed 35S-post labelling technique. The results will be compared with enzyme activities, mutational spectra, and localization of specific mutations determined by the other projects to develop an understanding of the role that chemical carcinogen adducts play in the development of human lung cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
POTENTIAL MUTAGENS AND CARCINOGENS
PILOT--DEVELOPE A LIVER CELL SYSTEM TO STUDY PROTEIN BINDING
N-NITROSO AND RELATED COMPOUNDS
CHEMISTRY OF GASTRIC CARCINOGENS
海外基金